Artículos de revistas
Redução do MELD em paciente na lista de transplante hepático após o uso de aminoácidos de cadeia ramificada: Relato de caso
Fecha
2014-01-01Registro en:
GED - Gastrenterologia Endoscopia Digestiva, v. 33, n. 2, p. 61-65, 2014.
0101-7772
2-s2.0-84994644950
Autor
Universidade Estadual Paulista (Unesp)
Institución
Resumen
Liver cirrhosis (LC) is a disease with high mortality rates and its only definitive treatment is the orthotopic liver transplantation (OLT). Unfortunately, not all patients have access to OLT and many of them end up dying on the transplant waiting list. The use of branched chain amino acids (BCAA) is widely known as an effective treatment for improving the quality of life of these patients. For the first time, in this paper we documented a great improvement of clinical and laboratorial tests of a patient treated with BCAA, which allowed him to be out of the transplant waiting list. In addition to the increase of the MELD score, the patient achieved restabilization of body weight and recovery of the quality of life registered by the SF-36 questionnaire.